Peptidergic granules in trigeminal ganglion neurons
三叉神经节神经元中的肽能颗粒
基本信息
- 批准号:7630547
- 负责人:
- 金额:$ 2.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-10 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAntibodiesBiochemicalBiotinylationCell FractionationCell surfaceConfocal MicroscopyCytoplasmic GranulesDegradation PathwayDense Core VesicleEndocytosisEndoplasmic ReticulumEventFluorescence Recovery After PhotobleachingFluorescent ProbesGoalsHomeostasisImmune SeraIntegral Membrane ProteinKineticsLifeMembraneMembrane Protein TrafficMembrane ProteinsMethodsMixed Function OxygenasesMorphologyMutationNervous system structureNeuronsNeuropeptidesOpticsPathway interactionsPeptidesPhosphorylationPhosphotransferasesProcessProteinsRNA InterferenceRecombinantsRecyclingRoleRouteSecretory ComponentSecretory VesiclesStimulusStructure of trigeminal ganglionTestingVirusenhanced green fluorescent proteinin vivoinsightmutantpeptidylglycine alpha-amidating monooxygenasepreventresearch studytime usetrafficking
项目摘要
Description (provided by the applicant): Regulated secretion of neuropeptides is essential for maintaining homeostasis within the nervous system. This process relies on the proper assembly of peptide-containing large dense core vesicles (LDCVs, or secretory granules), which in turn requires coordinated machinery to synthesize the LDCV membrane, package soluble contents, and retrieve components for degradation or recycling. Although these trafficking events are critical to function, little is known regarding the biosynthetic or recycling pathways of LDCVs in neurons. The studies proposed will focus on the trafficking of peptidylglycine alpha-amidating monooxygenase (PAM), an integral granule membrane protein known to carry out the last steps in the peptide biosynthetic pathway. The cytosolic domain of PAM contains routing information and is phosphorylated by the kinase PCIP2 at Ser949. This proposal will specifically test the hypothesis that PAM-1 is a dynamic component of secretory membranes in peptidergic neurons of the trigeminal ganglion, and that specific trafficking steps are regulated by phosphorylation at Ser949 by P-CIP2.
描述(由申请人提供):神经肽的调节分泌对于维持神经系统内的稳态至关重要。该过程依赖于含肽大致密核心囊泡(LDCV 或分泌颗粒)的正确组装,而这又需要协调的机器来合成 LDCV 膜、包装可溶性内容物并回收组分以供降解或回收。尽管这些转运事件对于功能至关重要,但人们对 LDCV 在神经元中的生物合成或回收途径知之甚少。拟议的研究将重点关注肽基甘氨酸α-酰胺化单加氧酶(PAM)的运输,这是一种完整的颗粒膜蛋白,已知执行肽生物合成途径的最后步骤。 PAM 的胞质结构域包含路由信息,并被激酶 PCIP2 在 Ser949 处磷酸化。该提案将专门测试以下假设:PAM-1 是三叉神经节肽能神经元分泌膜的动态成分,并且特定的运输步骤由 P-CIP2 在 Ser949 处的磷酸化来调节。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline A Sobota其他文献
Jacqueline A Sobota的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline A Sobota', 18)}}的其他基金
Peptidergic granules in trigeminal ganglion neurons
三叉神经节神经元中的肽能颗粒
- 批准号:
6998336 - 财政年份:2005
- 资助金额:
$ 2.88万 - 项目类别:
Peptidergic granules in trigeminal ganglion neurons
三叉神经节神经元中的肽能颗粒
- 批准号:
7457782 - 财政年份:2005
- 资助金额:
$ 2.88万 - 项目类别:
Peptidergic granules in trigeminal ganglion neurons
三叉神经节神经元中的肽能颗粒
- 批准号:
7233168 - 财政年份:2005
- 资助金额:
$ 2.88万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 2.88万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 2.88万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 2.88万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 2.88万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 2.88万 - 项目类别:














{{item.name}}会员




